News

Share

Aa-+

Here is the latest news about the Montreal Heart Institute.

Subscribe to news feed
  • Montreal Heart Institute sets the record straight

    July 8, 2015

    The Institute provides the highest level of medical service
    to all patients — regardless of language

    The Montreal Heart Institute, whose reputation goes well beyond our borders, wishes to reiterate that it provides state-of-the-art cardiology services to all patients, regardless of the language they speak.

    Read more

  • Dalcor Pharma licenses a late-stage investigational drug following a major discovery by the MHI

    June 8, 2015

    DALCOR PHARMA LICENSES A LATE-STAGE INVESTIGATIONAL CARDIOVASCULAR DRUG FOLLOWING MAJOR DISCOVERY BY MONTREAL HEART INSTITUTE (MHI) SCIENTISTS

    New company DalCor to sponsor global phase III clinical trial to be led by MHI

    Read more

  • MHI and AstraZeneca to screen samples for cardiovascular and diabetes genetic traits

    May 13, 2015

    The Montreal Heart Institute (MHI) today announced a collaboration with AstraZeneca, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes.

    Read more

  • A new platform makes telemedicine even more accessible

    February 16, 2015

    Reacts, a company led by cardiologist/intensivist Dr. Yanick Beaulieu at the MHI, has produced an innovative platform for telehealth and other applications.

    Read more

  • The Institute Biobank Celebrates its 20,000th Participant

    February 4, 2015

    Audrey Sirois, a 26-year-old patient, has become the 20,000th participant in the Montreal Heart Institute Biobank. Eventually, the Biobank will help the Institute's specialists and researchers better understand the genetic bases and other risk factors of cardiovascular disease.

    Read more

  • A World First - Discovery of a personalized therapy for cardiovascular disease

    January 12, 2015

    Discovery of a personalized therapy for cardiovascular disease, by the research team of Dr. Jean-Claude Tardif, cardiologist and Director of the MHI Research Center. This discovery may also pave the way for a new era in cardiovascular medicine, with personalized or precision drugs.The detailed results are published in the prestigious Journal Circulation Cardiovascular Genetics.

    Read more

  • The Effect of Statins Influenced by Gene Profiles

    2014, October 28, 2014

    The Montreal Heart Institute Research Centre is once again pushing the limits of knowledge in personalized medicine. A meta-analysis combining the results of several pharmacogenomic studies and involving over 40,000 research subjects now makes it possible to demonstrate a different response to statins according to the patient's gene profile.

    Read more

  • Fish oil supplements have little effect on irregular heartbeat

    2014, October 14, 2014

    High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.

    Read more

  • The Montreal Heart Institute announces first use of miniature cardiac monitor, REVEAL LINQ™ ICM

    2014, May 13, 2014

    MONTRÉAL – May 13, 2014 – The Montreal Heart Institute today announced that it is the first hospital in Québec, and one of the first in Canada, to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient, the smallest implantable cardiac monitoring device available in the world. This device allows doctors to continuously monitor the heart rate of patients presenting with falls, fainting (loss of consciousness or syncope) and even unexplained stroke.

    Read more

  • Identification of genetic mutations involved in human blood diseases

    2014, April 28, 2014

    A study published today in Nature Genetics has revealed mutations that could have a major impact on the future diagnosis and treatment of many human diseases. Through an international collaboration, researchers at the Montreal Heart Institute (MHI) were able to identify a dozen mutations in the human genome that are involved in significant changes in complete blood counts and that explain the onset of sometimes severe biological disorders.

    Read more

Pages